Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 737, doi. 10.1007/s00262-008-0596-0
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 5
Results: 18
1
2
Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 769, doi. 10.1007/s00262-008-0555-9
- By:
- Publication type:
- Article
3
Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 777, doi. 10.1007/s00262-008-0614-2
- By:
- Publication type:
- Article
4
Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 641, doi. 10.1007/s00262-008-0585-3
- By:
- Publication type:
- Article
5
Immunosensitization with a Bcl-2 small molecule inhibitor.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 699, doi. 10.1007/s00262-008-0592-4
- By:
- Publication type:
- Article
6
Characterization of MHC class-I restricted TCRαβ<sup>+</sup> CD4<sup>−</sup> CD8<sup>−</sup> double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 709, doi. 10.1007/s00262-008-0593-3
- By:
- Publication type:
- Article
7
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 719, doi. 10.1007/s00262-008-0594-2
- By:
- Publication type:
- Article
8
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 809, doi. 10.1007/s00262-008-0649-4
- By:
- Publication type:
- Article
9
Ipilimumab: controversies in its development, utility and autoimmune adverse events.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 823, doi. 10.1007/s00262-008-0653-8
- By:
- Publication type:
- Article
10
Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 789, doi. 10.1007/s00262-008-0633-z
- By:
- Publication type:
- Article
11
Paradoxical concentration effect of a homodimerizing antibody against a human non-small cell lung cancer cell line.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 749, doi. 10.1007/s00262-008-0597-z
- By:
- Publication type:
- Article
12
Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 677, doi. 10.1007/s00262-008-0590-6
- By:
- Publication type:
- Article
13
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 665, doi. 10.1007/s00262-008-0588-0
- By:
- Publication type:
- Article
14
Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 687, doi. 10.1007/s00262-008-0591-5
- By:
- Publication type:
- Article
15
Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 729, doi. 10.1007/s00262-008-0595-1
- By:
- Publication type:
- Article
16
Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 759, doi. 10.1007/s00262-008-0599-x
- By:
- Publication type:
- Article
17
HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 653, doi. 10.1007/s00262-008-0587-1
- By:
- Publication type:
- Article
18
TNK cells (NKG2D<sup>+</sup> CD8<sup>+</sup> or CD4<sup>+</sup> T lymphocytes) in the control of human tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 801, doi. 10.1007/s00262-008-0635-x
- By:
- Publication type:
- Article